+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oligonucleotide Synthesis Market by Product Type (Equipment/Instruments, Reagents & Consumables, Software & Services), Synthesis Scale (Custom Oligonucleotide Synthesis, Large-Scale/Commercial Manufacturing), Delivery Method, Application, End-User - Global Forecast 2025-2030- Product Image
Oligonucleotide Synthesis Market by Product Type (Equipment/Instruments, Reagents & Consumables, Software & Services), Synthesis Scale (Custom Oligonucleotide Synthesis, Large-Scale/Commercial Manufacturing), Delivery Method, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Oligonucleotide Synthesis Market by Product Type (Equipment/Instruments, Reagents & Consumables, Software & Services), Synthesis Scale (Custom Oligonucleotide Synthesis, Large-Scale/Commercial Manufacturing), Delivery Method, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337611
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oligonucleotide synthesis market stands at the forefront of enabling precision medicine, diagnostics, and biotechnology research. Senior decision-makers are navigating a rapidly evolving landscape driven by advancements in automation, digital integration, and sustainability, all reshaping expectations for speed, customization, and regulatory alignment.

Market Snapshot: Oligonucleotide Synthesis Market Growth Trajectory

The oligonucleotide synthesis market grew from USD 8.81 billion in 2024 to USD 10.28 billion in 2025. It is expected to continue growing at a CAGR of 16.91%, reaching USD 22.51 billion by 2030. This dynamic expansion reflects strong demand from pharmaceutical, biotechnology, and research organizations seeking innovative solutions for diagnostics, therapeutics, and academic research applications.

Scope & Segmentation

  • Product Types: Equipment and instruments such as DNA/RNA synthesizers and microarray synthesizers, reagents and consumables including enzymes, labeling agents, purification and synthesis chemicals, comprehensive software and services featuring bioinformatics tools, cloud storage, custom synthesis services, and data analysis platforms, as well as synthesized DNA and RNA oligonucleotides optimized for varied applications.
  • Synthesis Scales: Custom oligonucleotide synthesis for research and large-scale or commercial manufacturing for therapeutic and diagnostic developers.
  • Delivery Methods: Enzymatic synthesis and solid-phase synthesis technologies addressing efficiency and downstream processing needs.
  • Applications: Diagnostics (biosensors, molecular imaging, PCR, sequencing), drug discovery and development (lead optimization, target validation), research (functional genomics, gene expression, gene synthesis), and therapeutics (antisense therapy, CRISPR-based therapeutics, RNA interference).
  • End-User Segments: Academic and research institutes, contract research organizations, diagnostic laboratories, and pharma and biotech companies, each with specific service models and requirements.
  • Regional Focus: Americas led by the United States, Canada, Mexico, Brazil, and Argentina; Europe, Middle East & Africa covering the UK, Germany, France, several European and Middle Eastern countries, and Africa; Asia-Pacific including China, India, Japan, Australia, South Korea, and Southeast Asia.
  • Leading Companies: Key players include Agilent Technologies, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Eurofins Genomics, GE HealthCare Technologies, and others across manufacturing, reagent supply, and service provision.

Key Takeaways for Decision-Makers

  • Technological innovation in chemical and enzymatic synthesis, together with automation and bioinformatics, is accelerating custom oligonucleotide production and improving sequence accuracy.
  • Personalized medicine is driving increased demand for bespoke oligonucleotides tailored to individual patient profiles, advancing therapeutic and diagnostic capabilities.
  • Greener chemistries and sustainability initiatives reduce hazardous waste and support regulatory compliance, aligning with evolving industry standards and environmental stewardship principles.
  • Integrated digital solutions, including machine learning and advanced informatics, are optimizing reagent management and synthesis workflows for improved efficiency and consistency.
  • Collaborative networks between manufacturers, contract research organizations, and academic institutions are rapidly co-developing next-generation oligonucleotide solutions and expanding market reach.
  • Regulatory engagement and scenario planning enable organizations to stay ahead in compliance, quality, and supply chain resilience.

Tariff Impact: Navigating Supply Chain and Manufacturing Economics

The 2025 United States tariff adjustments have introduced complex supply chain pressures, raising costs for essential raw materials such as phosphoramidites and enzymes. Market participants are actively reevaluating procurement strategies, cultivating alternative supplier relationships, and regionalizing manufacturing to buffer against tariff-driven uncertainties. These external pressures are enhancing industry focus on flexibility, predictive analytics, and risk management frameworks to preserve competitiveness and ensure consistent supply.

Methodology & Data Sources

This report applies a rigorous mixed-method research approach, combining in-depth secondary research from journals, patents, regulatory filings, and white papers with extensive interviews of market experts. Data triangulation and validation protocols ensure all insights are accurate and reliable, benefiting from both qualitative and quantitative perspectives.

Why This Report Matters for Senior Leaders

  • Enables strategic planning through actionable segmentation and regional intelligence, supporting targeted investments and operational decisions in oligonucleotide synthesis.
  • Provides insights into technology adoption, regulatory trends, and environmental requirements, essential for minimizing risk and maintaining compliance in a shifting landscape.
  • Highlights emerging opportunities for innovation, collaboration, and supply chain strengthening, empowering leadership to drive differentiation and sustainable growth.

Conclusion

Oligonucleotide synthesis continues to transform research, diagnostics, and therapeutics. This comprehensive analysis equips decision-makers with the data-driven insights and strategies needed to navigate ongoing market evolution and advance organizational objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive analytics to optimize oligonucleotide yield and purity
5.2. Growing adoption of enzymatic synthesis platforms to streamline long oligonucleotide production
5.3. Scale-up of automated microfluidic systems for high-throughput oligonucleotide assembly
5.4. Rising need for mRNA vaccine precursors fueling advancements in oligonucleotide manufacturing
5.5. Development of multiplexed synthesis arrays to support personalized antisense therapeutic pipelines
5.6. Real-time process analytical technologies enhancing quality control in oligonucleotide synthesis
5.7. Expansion of novel phosphoramidite chemistries to improve coupling efficiency and fidelity
5.8. Adoption of advanced enzymatic synthesis platforms enabling efficient long-chain oligonucleotide assembly for therapeutics
5.9. Development of high-density multiplexed synthesis arrays to accelerate personalized antisense oligonucleotide pipeline development
5.10. Integration of machine learning algorithms to predict and optimize oligonucleotide synthesis outcomes for enhanced yield and purity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oligonucleotide Synthesis Market, by Product Type
8.1. Introduction
8.2. Equipment/Instruments
8.2.1. DNA/RNA Synthesizers
8.2.2. Microarray Synthesizers
8.3. Reagents & Consumables
8.3.1. Enzymes
8.3.2. Labeling Reagents
8.3.3. Purification Reagents
8.3.4. Synthesis Reagents
8.4. Software & Services
8.4.1. Bioinformatics Tools
8.4.2. Cloud Storage & Management Solution
8.4.3. Custom Oligo Synthesis Services
8.4.4. Data Analysis Platforms
8.5. Synthesized Oligonucleotides
8.5.1. DNA Oligonucleotides
8.5.2. RNA Oligonucleotides
9. Oligonucleotide Synthesis Market, by Synthesis Scale
9.1. Introduction
9.2. Custom Oligonucleotide Synthesis
9.3. Large-Scale/Commercial Manufacturing
10. Oligonucleotide Synthesis Market, by Delivery Method
10.1. Introduction
10.2. Enzymatic Synthesis
10.3. Solid-Phase Synthesis
11. Oligonucleotide Synthesis Market, by Application
11.1. Introduction
11.2. Diagnostics
11.2.1. Biosensors
11.2.2. Molecular Imaging
11.2.3. PCR & Sequencing
11.3. Drug Discovery & Development
11.3.1. Lead Optimization
11.3.2. Target Validation
11.4. Research
11.4.1. Functional Genomics
11.4.2. Gene Expression Analysis
11.4.3. Gene Synthesis
11.5. Therapeutics
11.5.1. Antisense Therapy
11.5.2. CRISPR-Based Therapeutics
11.5.3. RNA Interference
12. Oligonucleotide Synthesis Market, by End-User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Contract Research Organizations
12.4. Diagnostic Laboratories
12.5. Pharmaceutical & Biotechnology Companies
13. Americas Oligonucleotide Synthesis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Oligonucleotide Synthesis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Oligonucleotide Synthesis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Agilent Technologies, Inc.
16.3.2. Ajinomoto Bio-Pharma Services
16.3.3. Bio-synthesis Inc.
16.3.4. LGC Genomics Limited
16.3.5. Danaher Corporation
16.3.6. Eurofins Genomics LLC
16.3.7. Eurogentec S.A. by Kaneka Corporation
16.3.8. GE HealthCare Technologies Inc.
16.3.9. Genscript Corporation
16.3.10. Merck KGaA
16.3.11. Nitto Denko Avecia Inc.
16.3.12. Thermo Fisher Scientific Inc.
16.3.13. Maravai Intermediate Holdings, LLC
16.3.14. Biolegio B.V.
16.3.15. Biolytic Lab Performance Inc.
16.3.16. Microsynth AG
16.3.17. parent added
16.3.18. PerkinElmer, Inc.
16.3.19. TAG Copenhagen A/S
16.3.20. Generi Biotech
16.3.21. Biocomma Ltd.
16.3.22. Hongene Biotech Corp.
16.3.23. TCI Chemicals (India) Pvt. Ltd.
16.3.24. Creative Biogene
16.3.25. Cusabio Technology LLC
16.3.26. Synbio Technologies
16.3.27. REPROCELL Inc.
16.3.28. Bon Opus Biosciences, LLC
16.3.29. Novartis AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHAI
FIGURE 26. OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHSTATISTICS
FIGURE 27. OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHCONTACTS
FIGURE 28. OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA/RNA SYNTHESIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA/RNA SYNTHESIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY SYNTHESIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY SYNTHESIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PURIFICATION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PURIFICATION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CLOUD STORAGE & MANAGEMENT SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CLOUD STORAGE & MANAGEMENT SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGO SYNTHESIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGO SYNTHESIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LARGE-SCALE/COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LARGE-SCALE/COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR & SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR & SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR-BASED THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR-BASED THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 172. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 173. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 174. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 175. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 176. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 177. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 178. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 179. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 180. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 181. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 182. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 183. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 188. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 189. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 192. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 193. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 200. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 201. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 208. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 209. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 214. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 215. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 216. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 217. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT/INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS SCALE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM OLIGONUC

Samples

Loading
LOADING...

Companies Mentioned

  • Agilent Technologies, Inc.
  • Ajinomoto Bio-Pharma Services
  • Bio-synthesis Inc.
  • LGC Genomics Limited
  • Danaher Corporation
  • Eurofins Genomics LLC
  • Eurogentec S.A. by Kaneka Corporation
  • GE HealthCare Technologies Inc.
  • Genscript Corporation
  • Merck KGaA
  • Nitto Denko Avecia Inc.
  • Thermo Fisher Scientific Inc.
  • Maravai Intermediate Holdings, LLC
  • Biolegio B.V.
  • Biolytic Lab Performance Inc.
  • Microsynth AG
  • parent added
  • PerkinElmer, Inc.
  • TAG Copenhagen A/S
  • Generi Biotech
  • Biocomma Ltd.
  • Hongene Biotech Corp.
  • TCI Chemicals (India) Pvt. Ltd.
  • Creative Biogene
  • Cusabio Technology LLC
  • Synbio Technologies
  • REPROCELL Inc.
  • Bon Opus Biosciences, LLC
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.51 Billion
Compound Annual Growth Rate16.9%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product (Oligonucleotides, Reagents, Services, Equipment/Synthesizer), By Application (PCR Primers, Sequencing, DNA Microarrays), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product (Oligonucleotides, Reagents, Services, Equipment/Synthesizer), By Application (PCR Primers, Sequencing, DNA Microarrays), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 135 Pages
  • Global
From
Oligonucleotide Synthesis Market Report by Product, End Use, and Region 2024-2032 - Product Image

Oligonucleotide Synthesis Market Report by Product, End Use, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030 - Product Image

Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030

  • Report
  • 456 Pages
  • Global
From
Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-Users, Company Size and Key Geographical Regions - Product Image

Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-Users, Company Size and Key Geographical Regions

  • Report
  • 325 Pages
  • Global
From
Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides - Product Image

Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides

  • Report
  • 406 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.